CompletedPHASE1, PHASE2NCT02667483

Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Studying Duchenne muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Daiichi Sankyo Co., Ltd.
Principal Investigator
Global Clinical Leader
Daiichi Sankyo
Intervention
DS-5141b(drug)
Enrollment
8 enrolled
Eligibility
5-10 years · MALE
Timeline
20152020

Study locations (2)

Collaborators

Daiichi Sankyo

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02667483 on ClinicalTrials.gov

Other trials for Duchenne muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Duchenne muscular dystrophy

← Back to all trials